← Leaderboards
Christopher Niyibizi
University Of Pittsburgh At Pittsburgh
$2,651,000
Attributed
$2,651,000
Total exposure
6
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $306.9K · FY2005–21$500K$375K$250K$125K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
Funding mix
By agency
NIH$2,651,000 · 6
By mechanism
R01$1,317,214 · 1
R21$1,297,888 · 4
R03$35,898 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Pittsburgh At Pittsburgh
Same institution · by research overlap
- David Alan Greenberg$16,853,059
- Jane Cauley$32,838,985
- Dong Moon Shin$11,702,631
- Johnny Huard$5,437,784
- Stephen D Meriney$4,868,096
Others in their field
Top investigators on “Osteogenesis Imperfecta”
- Brendan Hl Lee · Baylor College Of Medicine$21,386,215
- Darwin Johnson Prockop · Thomas Jefferson University$12,475,128
- David R. Eyre · University Of Washington$7,712,100
- Edwin M Horwitz · St. Jude Children'S Research Hospital$6,162,377
- David W Russell · University Of Washington$5,835,718
- Nate Robinson · Iq Solutions, Inc.$5,191,215
Research focus
Osteogenesis ImperfectaLaboratory MouseImmunofluorescence TechniqueOsteoblastsBone MarrowCollagenHistologyMesenchymal Stem CellsCell TransplantationProtocols DocumentationHarvestCellsAdultGene TherapyOsteogenesisNonhuman Therapy EvaluationDisease /Disorder ModelGenesGreater Sac Of PeritoneumBaseAgingGene MutationFetalBone
Grant awards (15)
Evaluation of pigment epithelium derived factor and its derived peptide for bone healing$173,046
R21 · FY2021 · AR · contact PI
Evaluation of pigment epithelium derived factor and its derived peptide for bone healing$214,077
R21 · FY2020 · AR · contact PI
Effect of Pigment Epithelium Derived Factor on Sclerostin expression by Osteocytes$170,170
R21 · FY2016 · AR · contact PI
Effect of Pigment Epithelium Derived Factor on Sclerostin expression by Osteocytes$204,204
R21 · FY2015 · AR · contact PI
Transplantability of induced pluripotent stem cells for skeletal tissues$167,508
R21 · FY2011 · AR · contact PI
Transplantability of induced pluripotent stem cells for skeletal tissues$209,385
R21 · FY2010 · AR · contact PI
STEM CELL THERAPY FOR DISEASES OF BONE IN A MOUSE MODEL$306,885
R01 · FY2005 · AR
STEM CELL THERAPY FOR DISEASES OF BONE IN A MOUSE MODEL$351,795
R01 · FY2004 · AR
STEM CELL THERAPY FOR DISEASES OF BONE IN A MOUSE MODEL$339,491
R01 · FY2003 · AR
STEM CELL THERAPY FOR DISEASES OF BONE IN A MOUSE MODEL$319,043
R01 · FY2002 · AR
EVALUATION OF CELLULAR GENE THERAPY FOR OI$72,642
R21 · FY2001 · AR
EVALUATION OF CELLULAR GENE THERAPY FOR OI$9,463
R21 · FY2001 · AR
EVALUATION OF CELLULAR GENE THERAPY FOR OI$4,733
R21 · FY2001 · AR
EVALUATION OF CELLULAR GENE THERAPY FOR OI$72,660
R21 · FY2000 · AR
CELL AND GENE THERAPY IN A MOUSE MODEL OF HUMAN OSTEOGEN$35,898
R03 · FY2000 · DE